Structure of Lovastatin
CAS No.: 75330-75-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.
Synonyms: Mevinolin; Monacolin K; Altoprev
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 75330-75-5 |
Formula : | C24H36O5 |
M.W : | 404.54 |
SMILES Code : | CC[C@H](C)C(O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(O3)=O)[C@@]12[H])=O |
Synonyms : |
Mevinolin; Monacolin K; Altoprev
|
MDL No. : | MFCD00072164 |
InChI Key : | PCZOHLXUXFIOCF-BXMDZJJMSA-N |
Pubchem ID : | 53232 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H351-H361 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Concentration | Treated Time | Description | References |
iPSC-ECs | 1 μM | 1 week | To evaluate the effect of lovastatin on LMNA iPSC-ECs function, results showed that lovastatin improved endothelial cell function, increased KLF2 and eNOS expression, and enhanced NO production and tube formation. | PMC7557117 |
iPSC-CMs | 1 μM | 1 week | To evaluate the effect of lovastatin on LMNA iPSC-CMs function, results showed that when co-cultured with iPSC-ECs, lovastatin improved cardiomyocyte function, enhancing contractility and relaxation. | PMC7557117 |
LS174T cells | 10 µM | 2 hours | To evaluate the accumulation and conversion rate of Lovastatin in LS174T cells, results showed that XZK and F1 significantly increased the accumulation and conversion rate of LvA. | PMC6289385 |
HepG2 cells | 10 µM | 2 hours | To evaluate the accumulation and conversion rate of Lovastatin in HepG2 cells, results showed that XZK and F1 significantly increased the accumulation and conversion rate of LvA. | PMC6289385 |
MOC1 cells | 500 nM or less | 120 hours | Lovastatin inhibited MOC1 cell proliferation and enhanced T-cell-mediated killing of tumor cells. | PMC9853267 |
TC-1 cells | 500 nM or less | 48 hours | Lovastatin inhibited TC-1 cell proliferation and enhanced T-cell-mediated killing of tumor cells. | PMC9853267 |
MDA-MB-231 | 1 μM | 48 h | Inhibited stemness properties including sphere formation and self-renewal capacity in TNBC MDA-MB-231 and 4T1 cells | PMC11008279 |
4T1 | 1 μM | 48 h | Inhibited stemness properties including sphere formation and self-renewal capacity in TNBC MDA-MB-231 and 4T1 cells | PMC11008279 |
MDA-MB-453 | 1 μM | 48 h | No significant effect on stemness properties in non-TNBC MDA-MB-453 cells | PMC11008279 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mice | Hypercholesterolemia model | Intraperitoneal injection | 10 mg/kg | daily for 5 days | To evaluate the effect of AGR2 on the lipid-lowering efficacy of Lovastatin, the results showed that AGR2 overexpression significantly reduced the lipid-lowering efficacy of Lovastatin | PMC9622889 |
C57BL/6 mice | High-fat diet-induced hyperlipidemia model | Oral | 40 mg | Once daily for 6 months to 18 months | To evaluate the pharmacokinetic behavior of Lovastatin in high-fat diet mice, results showed that XZK significantly increased the exposure of LvA and decreased the exposure of Lv. | PMC6289385 |
Mice | MOC1 tumor model | Oral | 10 mg/kg | Once daily for 2 weeks | Lovastatin combined with PD-1 blockade enhanced tumor control and extended survival, with rejection of tumors in 30% of mice treated with lovastatin plus anti-PD-1. | PMC9853267 |
Nude mice | Orthotopic tumor model of TNBC | Intragastric administration | 60 mg/kg | Once daily for 3 weeks | Lovastatin significantly inhibited tumor growth in mice inoculated with MDA-MB-231 SFCs but not MDA-MB-453 SFCs | PMC11008279 |
C57BL/6J mice | High-fat diet-induced obese mice | Gastric irrigation | 30 mg/kg/day | Once daily for 6 weeks | To study the effect of corylin on lipid metabolism in obese mice, results showed that corylin significantly reduced body weight, serum TC, TG, and LDL-c levels, and increased HDL-c levels. | PMC6735373 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01047683 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT00256750 | Kidney Transplantation ... More >> Chronic Kidney Failure Less << | Phase 3 | Completed | - | - |
NCT01047501 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT00256750 | - | Completed | - | - | |
NCT01492361 | Cardiovascular Diseases | Phase 3 | Completed | - | - |
NCT02523001 | - | Completed | - | Italy ... More >> Department of Biomedical Sciences Human Oncology - Clinica Medica "A. Murri" Bari, Italy, 70124 Less << | |
NCT00132717 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT03739242 | Hypercholesterolemia | Not Applicable | Completed | - | Italy ... More >> Policlinico S.Orsola - Malpighi Medicina Interna Borghi Bologna, Italy, 40138 Less << |
NCT01890967 | - | Completed | - | - | |
NCT03510715 | Hypercholesterolemia | Phase 3 | Recruiting | June 2020 | United States, California ... More >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 Less << |
NCT03510884 | Hypercholesterolaemia | Phase 3 | Recruiting | March 2022 | - |
NCT00532311 | Hypercholesterolemia | Phase 3 | Terminated(Overall profile of ... More >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) Less << | - | - |
NCT03065491 | Hypercholesterolemia | Not Applicable | Completed | - | Italy ... More >> S. Orsola-Malpighi University Hospital Bologna, BO, Italy, 40138 Less << |
NCT00986583 | Pain | Not Applicable | Completed | - | United States, Ohio ... More >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less << |
NCT01890967 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT02969070 | Hypercholesterolemia ... More >> Endothelial Dysfunction Less << | Phase 3 | Unknown | March 2017 | Italy ... More >> University of Naples "Federico II" Recruiting Naples, Italy, 80131 Contact: Giuseppe Giugliano, MD, PhD +390817462240 giuseppe.giugliano@unina.it Sub-Investigator: Raffaele Izzo, MD Sub-Investigator: Maurizio Galderisi, MD Sub-Investigator: Giuseppe Giugliano, MD, PhD Less << |
NCT00986583 | - | Completed | - | - | |
NCT03425630 | Hypercholesterolemia | Not Applicable | Completed | - | - |
NCT02142569 | Cholesterol Lowering | Phase 2 Phase 3 | Suspended(We were unable to pr... More >>ocure the supplement for this study.) Less << | July 2018 | United States, California ... More >> UCLA Center for Human Nutrition, 900 Veteran Avenue, WH 14-187 Los Angeles, California, United States, 90095 Less << |
NCT00726362 | - | Completed | - | Taiwan ... More >> Research Site Changhua, Taiwan Research Site Hualien, Taiwan Research Site Kaohsiung, Taiwan Research Site Pingtung, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Yun-Lin, Taiwan Less << | |
NCT01807078 | Coronary Artery Disease | Phase 4 | Unknown | December 2017 | Italy ... More >> Sapienza University Not yet recruiting Rome, Lazio, Italy, 00161 Contact: Francesco Pelliccia, MD +39064997 ext 123 f.pelliccia@mclink.it Contact: Giuseppe Marazzi, MD +39064997 ext 123 md4151@mclink.it Principal Investigator: Francesco Pelliccia, MD Less << |
NCT00452244 | Lung Cancer | Phase 2 | Completed | - | Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less << |
NCT00145574 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00145574 | - | Completed | - | - | |
NCT00046358 | Alzheimer Disease | Phase 4 | Completed | - | United States, Maryland ... More >> National Institute of Mental Health (NIMH) Bethesda, Maryland, United States, 20892 Less << |
NCT02518503 | - | Completed | - | - | |
NCT02603276 | Hypercholesterolemia | Not Applicable | Completed | - | Italy ... More >> S. Orsola-Malpighi University Hospital Bologna, Italy, 40038 Less << |
NCT02518516 | - | Completed | - | Canada, British Columbia ... More >> Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 Less << | |
NCT00125125 | Dyslipidemia | Phase 4 | Completed | - | United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less << |
NCT01087632 | Metabolic Syndrome | Not Applicable | Completed | - | Italy ... More >> Federico II University - Department of Internal Medicine Naples, Italy Less << |
NCT00730132 | - | Completed | - | - | |
NCT03216811 | Hypercholesterolemia | Phase 2 | Completed | - | Italy ... More >> University Hospital of Ferrara Cona, Ferrara, Italy, 44124 Less << |
NCT00000463 | Cardiovascular Diseases ... More >> Coronary Disease Heart Diseases Myocardial Ischemia Less << | Phase 3 | Completed | - | - |
NCT02492464 | Atherosclerosis | Not Applicable | Completed | - | Italy ... More >> S. Orsola-Malpighi University Hospital Bologna, BO, Italy, 40138 Less << |
NCT00730132 | - | Completed | - | - | |
NCT01269762 | Healthy Volunteer | Phase 4 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less << |
NCT03470376 | Hypercholesterolemia ... More >> Inflammation Atherosclerosis Less << | Phase 4 | Completed | - | - |
NCT02658838 | LOVASTATIN/TICAGRELOR [VA Drug... More >> Interaction] Less << | Phase 4 | Unknown | September 2017 | China, Beijing ... More >> Beijing Anzhen Hosipital Beijing, Beijing, China, 100000 Less << |
NCT01569854 | - | Withdrawn(Insufficient recruit... More >>ment) Less << | March 2022 | United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << | |
NCT00718796 | Cardiovascular Disease | Phase 3 | Completed | - | Canada, Ontario ... More >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 Less << |
NCT01385020 | Healthy Subjects | Phase 4 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less << |
NCT00000477 | Atherosclerosis ... More >> Cardiovascular Diseases Coronary Disease Heart Diseases Hypercholesterolemia Myocardial Ischemia Less << | Phase 2 | Completed | - | - |
NCT01569867 | - | Recruiting | March 2022 | United States, Ohio ... More >> The Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: Joseph P Kitzmiller, MD PhD Sub-Investigator: Wolfgang Sadee, Dr rer nat Sub-Investigator: Mitch Phelps, PhD Sub-Investigator: Rebecca Jackson, MD Less << | |
NCT02689934 | Hypercholesterolemia | Not Applicable | Completed | - | Italy ... More >> Centro Dislipidemie Dip. Cardiotoracovasc ASST Grande Ospedale Metropolitano Niguarda Cà Granda Milano, Mi, Italy, 20162 Less << |
NCT00092846 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02964884 | Neurofibromatosis Type 1 ... More >> Learning Disability Reading Disability NF1 Less << | Phase 2 | Recruiting | June 2022 | United States, Tennessee ... More >> Vanderbilt University Recruiting Nashville, Tennessee, United States Contact: Laura E. Cutting 615-875-1054 Less << |
NCT03340285 | Cardiovascular Risk Factor | Not Applicable | Not yet recruiting | April 2018 | - |
NCT00000512 | Cardiovascular Diseases ... More >> Coronary Arteriosclerosis Coronary Disease Heart Diseases Myocardial Ischemia Less << | Phase 3 | Completed | - | - |
NCT00000469 | Cardiovascular Diseases ... More >> Carotid Stenosis Cerebral Arteriosclerosis Cerebrovascular Disorders Heart Diseases Vascular Diseases Less << | Phase 2 | Completed | - | - |
NCT02862470 | - | Active, not recruiting | July 7, 2020 | - | |
NCT03504501 | Impaired Synaptic Plasticity ... More >> Impaired Cognition Less << | Phase 2 | Recruiting | June 2019 | Germany ... More >> Technical University Munich Recruiting Munich, Germany, 81377 Contact: Volker Mall, Prof. +49 (0)89 71009-233 volker.mall@kbo.de Contact: Nikolai Jung, Dr. +49 (0)89 71009-236 nikolai.jung@tum.de Less << |
NCT00741013 | Lung Inflammation | Early Phase 1 | Completed | - | United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less << |
NCT00004346 | Cerebrotendinous Xanthomatosis | Phase 2 | Unknown | - | United States, Oregon ... More >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239-3098 Contact: Sonja Connor 503-494-7775 connors@ohsu.edu Less << |
NCT00116870 | Atherosclerosis ... More >> Coronary Artery Disease Less << | Phase 2 Phase 3 | Completed | - | United States, California ... More >> Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine Los Angeles, California, United States, 90033 Less << |
NCT01250535 | Healthy Volunteers ... More >> Drug Drug Interactions Less << | Phase 1 | Completed | - | United States, North Carolina ... More >> University of North Carolina, Clinical and Translational Research Center (CTRC) Chapel Hill, North Carolina, United States, 27599 Less << |
NCT03763175 | Irritable Bowel Syndrome With ... More >>Constipation Less << | Phase 2 | Not yet recruiting | January 1, 2020 | United States, California ... More >> Cedars-Sinai Medical Center Not yet recruiting Los Angeles, California, United States, 90048 Contact: Tahli Singer-Englar 310-423-3792 tahli.singerenglar@cshs.org Less << |
NCT01361217 | - | Completed | - | - | |
NCT00062556 | Intermittent Claudication ... More >> Peripheral Vascular Disease Less << | Phase 3 | Completed | - | - |
NCT00345657 | Hyperlipidemia ... More >> Mixed Hyperlipidemia Dyslipidemia Less << | Phase 4 | Completed | - | United States, Oklahoma ... More >> Family Medical Care of Tulsa Tulsa, Oklahoma, United States, 74136 Less << |
NCT00741013 | - | Completed | - | - | |
NCT01976936 | Stroke Rhabdo... More >>myolysis Jaundice Less << | Phase 2 | Completed | - | United States, California ... More >> University of California, Los Angeles Stroke Network Los Angeles, California, United States, 90024 United States, Florida Jackson Memorial Hospital Miami, Florida, United States, 33136 University of Miami Miller School of Medicine Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Pennsylvania The Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less << |
NCT01361217 | Drug-Drug Interaction ... More >> Healthy Volunteers Less << | Not Applicable | Completed | - | - |
NCT00721305 | HIV Seropositivity | Phase 2 | Completed | - | Colombia ... More >> Group of Immunovirology, Research Universitary Center, University of Antioquia Medellin, Antioquia, Colombia Less << |
NCT00071266 | Intermittent Claudication ... More >> Peripheral Vascular Disease Less << | Phase 3 | Completed | - | - |
NCT00902668 | Breast Cancer ... More >> Radiation Toxicity Less << | Phase 2 | Terminated(Slow accrual) | - | - |
NCT00902668 | - | Terminated(Slow accrual) | - | - | |
NCT00689806 | Severe Persistent Asthma | Phase 1 Phase 2 | Withdrawn(Study never opened) | - | - |
NCT02998151 | Fragile X Syndrome | Phase 2 | Enrolling by invitation | July 2021 | United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less << |
NCT00462280 | - | Completed | - | - | |
NCT00853580 | Neurofibromatosis Type 1 | Phase 2 | Completed | - | United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland NIH Bethesda, Maryland, United States, 20892 United States, Massachusetts Children' Hospital Boston Boston, Massachusetts, United States, 02115 United States, Missouri Washington University - St. Louis Saint Louis, Missouri, United States, 63110 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19096 United States, Texas Childrens Medical Center - Univ. of Texas SW Medical Center Dallas, Texas, United States, 75235 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Australia, New South Wales The Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Less << |
NCT01110642 | Syndromic Ichthyoses|CHILD Syn... More >>drome|Smith Lemli Opitz Syndrome|Conradi Syndrome Less << | PHASE2 | WITHDRAWN | - | - |
NCT00243880 | Stroke | Phase 1 | Completed | - | United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less << |
NCT03178526 | Alveolar Bone Loss, Chronic Pe... More >>riodontitis, Lovestatin Gel, Regeneration Less << | Phase 2 Phase 3 | Completed | - | - |
NCT00352599 | Neurofibromatosis 1 | Phase 1 | Completed | - | United States, California ... More >> Semel Institute for Neuroscience and Human Behavior Los Angeles, California, United States, 90095 Less << |
NCT00462280 | Precancerous Condition ... More >> Stage 0 Melanoma Stage I Melanoma Stage II Melanoma Less << | Phase 2 | Completed | - | United States, California ... More >> University of California Medical Center At Irvine-Orange Campus Orange, California, United States, 92868 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less << |
NCT02563860 | Rett Syndrome | PHASE2 | COMPLETED | 2025-07-16 | Montefiore Medical center, Bro... More >>nx, New York, 10467, United States Less << |
NCT02389868 | Blood Platelets Proteome | PHASE2 | COMPLETED | 2025-06-15 | Centre de Recherche du CHUS, S... More >>herbrooke, Quebec, J1H 5N4, Canada Less << |
NCT00302952 | Rheumatoid Arthritis | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Aurora, Colorado, United States, 80095 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Michigan Justus J. Fiechtner, MD, PLLC Lansing, Michigan, United States, 48910 United States, New York Feinstein Institute for Medical Research NS-LIJ Health System Manhasset, New York, United States, 11030 University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Carolina Bone and Joint Charlotte, North Carolina, United States, 29425 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15261 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor Research Institute Dallas, Texas, United States, 75231 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less << |
NCT00853580 | - | Completed | - | - | |
NCT00302952 | - | Completed | - | - | |
NCT00584012 | - | Terminated(Funding issues) | - | - | |
NCT00685685 | Healthy | Phase 1 | Completed | - | Canada ... More >> Algorithme Pharma Montreal, Canada, H7V 4B4 Less << |
NCT00700921 | Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << | Phase 2 | Completed | - | United States, Colorado ... More >> National Jewish Medical and Research Center Denver, Colorado, United States, 80206 Less << |
NCT00684723 | Healthy | Phase 1 | Completed | - | Canada, Quebec ... More >> Algorithme Pharma Montreal, Quebec, Canada Less << |
NCT00584012 | Any Cancer Br... More >>east Cancer Less << | Phase 1 | Terminated(Funding issues) | - | United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less << |
NCT00685685 | - | Completed | - | - | |
NCT00583102 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Terminated(Slow accrual, PI le... More >>ft institution) Less << | - | United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less << |
NCT00963664 | Melanoma Mali... More >>gnant Melanoma Less << | Phase 2 | Withdrawn(Modifications will b... More >>e necessary before full IRB approval will be secured.) Less << | December 2016 | United States, Tennessee ... More >> NeoPlas Innovation Nashville, Tennessee, United States, 37027 Less << |
NCT00684723 | - | Completed | - | - | |
NCT00285857 | Breast Cancer | PHASE2 | TERMINATED | 2025-12-10 | Stanford University Cancer Cen... More >>ter, Stanford, California, 94305, United States Less << |
NCT02603770 | Lipid Metabolism Disorder | Phase 1 | Completed | - | United States, California ... More >> NRC Research Institute Orange, California, United States, 92868 Less << |
NCT00583102 | - | Terminated(Slow accrual, PI le... More >>ft institution) Less << | - | - | |
NCT00580970 | Prostate Cancer | Phase 2 | Completed | - | United States, Virginia ... More >> Hunter Holmes McGuire Veterans Administration Medical Center Richmond, Virginia, United States, 23249 Massey Cancer Center/Virginia Commonwealth University Richmond, Virginia, United States, 23298 Southside Regional Medical Center Richmond, Virginia, United States, 23805 Less << |
NCT02642653 | Fragile X Syndrome ... More >> Genetic Diseases Less << | Phase 4 | Completed | - | United States, California ... More >> UC Davis MIND Institute Sacramento, California, United States, 95817 Less << |
NCT00580970 | - | Completed | - | - | |
NCT00585052 | Ovarian Cancer | Phase 2 | Terminated(Slow accrual, PI le... More >>ft the institution) Less << | - | United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52327 Less << |
NCT00585052 | - | Terminated(Slow accrual, PI le... More >>ft the institution) Less << | - | - | |
NCT01346670 | Healthy Volunteer | Phase 4 | Completed | - | Taiwan ... More >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Less << |
NCT01527669 | Healthy Subjects | Phase 4 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less << |
NCT01478828 | Prostate Cancer | TERMINATED | 2013-04-08 | The Sidney Kimmel Comprehensiv... More >>e Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231, United States Less << | |
NCT02680379 | Fragile X Syndrome | Phase 2 | Completed | - | Canada, Quebec ... More >> Centre de Recherche du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less << |
NCT03242499 | Parkinson Disease | Phase 2 | Recruiting | December 31, 2019 | Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chin-Hsien Lin, MD,PhD 886-2-3123456 ext 65335 chlin@ntu.edu.tw Principal Investigator: Chin-Hsien Lin, MD,PhD Less << |
NCT01478828 | Prostate Cancer | TERMINATED | 2013-04-08 | The Sidney Kimmel Comprehensiv... More >>e Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231, United States Less << | |
NCT00285857 | Breast Cancer | PHASE2 | TERMINATED | 2025-12-10 | Stanford University Cancer Cen... More >>ter, Stanford, California, 94305, United States Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.47mL 0.49mL 0.25mL |
12.36mL 2.47mL 1.24mL |
24.72mL 4.94mL 2.47mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|